October 29, 2013 – Two years after its creation, the Psoriasis Institute is stepping up its action for better patient and disease management.
In 2010, the Paris Saint-Joseph Hospital Group (GHPSJ) created the first hospital center dedicated to the multidisciplinary therapeutic management of skin psoriasis and psoriatic arthritis.
Two years after its creation, the Institute decided to work on a new area of development: improving screening for cardiovascular risk factors, and opening a new consultation window to best meet the strong demand from patients. (600 patients treated each year).
Patients with psoriasis and psoriatic arthritis have a higher prevalence of
cardiovascular risk factors such as hypertension and hypercholesterolemia… The Institute is working on a joint rheumatologist-dermatologist-cardiologist monitoring project in order to allow the early and effective detection and management of these factors of cardiovascular co-morbidities.
Since 2010, the Institute has developed a multidisciplinary dermatology / rheumatology offer for all forms of psoriasis. The symptoms of psoriasis are multiple and can cause joint damage to the patient. A dermatological approach alone therefore appears most often insufficient to effectively treat this disease.
Thanks to this dedicated Institute, patients have the possibility of being jointly monitored by the medical teams of the dermatology and rheumatology departments through:
- Dedicated and on-demand dermatological consultations (Dr. Lons-Danic);
- Rheumatological treatment (team of Dr. Rajzbaum);
- A metabolic evaluation;
- A more complete health check-up in a day hospital (HDJ) for patients with the most serious forms;
- All treatments for the condition: from UVA / UVB phototherapy to biological therapies in HDJ.
“Our care offer, through this dedicated Institute, is unique in Ile-de-France. Our medical expertise makes it possible to cover all of the patient’s care needs over the long term; just as we pay special attention to psychological support, psoriasis being a disease that impairs the quality of life. »Underline Dr Lons-Danic and Rajzbaum.
